<DOC>
	<DOCNO>NCT00492102</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetics ( PK ) montelukast ( Singulair ) low birth weight ( VLBW ) infant risk develop bronchopulmonary dysplasia ( need supplemental oxygen ) . The investigator ' long-term hypothesis inhibition leukotriene signal VLBW preterm lung decrease inflammation , remodel incidence bronchopulmonary dysplasia ( BPD ) .</brief_summary>
	<brief_title>Montelukast Very Low Birthweight Infants</brief_title>
	<detailed_description>This study proposal determine pharmacokinetics ( PK ) montelukast ( cysteinyl leukotriene receptor-1 CysLT1 inhibitor ) low birth weight ( VLBW ) infants 500 - 1500g birth weight risk develop bronchopulmonary dysplasia ( BPD ) . Montelukast ( Singulair ) FDA approve specific CysLT1 antagonist widely use clinically prophylaxis asthma child older 12 month age block leukotriene signal lung . BPD share pathogenic mechanism asthma , however Cysteinyl LT receptor blockade studied preterm infant . Montelukast metabolize cytochrome P450 system immature preterm infant hence need study . The investigator ' long-term hypothesis inhibition leukotriene signal VLBW preterm lung decrease inflammation , remodel incidence BPD . The data use design future efficacy trial Montelukast prevention bronchopulmonary dysplasia .</detailed_description>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>VLBW infant 500 1500 gm birthweight born Good Samaritan Hospital , Cincinnati , tolerate oral feed equal 75 ml/kg/day old 7 day Infants diagnose congenital malformation . Infants acute life threaten illness . Grade III IV intraventricular hemorrhage . Patent ductus arteriosus treat indomethacin . Oral feeding contraindicate . Parents refuse consent . Attending physician wish infant enrol study . Infants know hepatitis HIV . Infants enrol study use investigational drug .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>Montelukast</keyword>
	<keyword>bronchopulmonary dysplasia</keyword>
	<keyword>Pharmacokinetics Montelukast</keyword>
</DOC>